| MDMA | Q69488 |
| scholarly article | Q13442814 |
| P50 | author | Adam Stewart | Q63861480 |
| Alan P Newman | Q83168575 | ||
| Katie H K Chang | Q89504172 | ||
| Allan V Kalueff | Q89613607 | ||
| Molly Hook | Q114575748 | ||
| Eli Utterback | Q114575749 | ||
| Peter Hart | Q37834791 | ||
| Evan Kyzar | Q37834801 | ||
| Jonathan Cachat | Q37834814 | ||
| Siddharth Gaikwad | Q56722527 | ||
| P2093 | author name string | Keith Wong | |
| Jeremy Green | |||
| Jessica Cosgrove | |||
| Russell Riehl | |||
| Alexander Allain | |||
| Kate Rhymes | |||
| Karoly Vollmer | |||
| P2860 | cites work | The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain | Q28283369 |
| The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs | Q28361466 | ||
| Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice | Q30946517 | ||
| Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement | Q33269030 | ||
| Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats | Q67729353 | ||
| Effect of lysergic acid diethylamide on the surfacing behaviour of large carp | Q79330656 | ||
| Zebrafish Behavior in Novel Environments: Effects of Acute Exposure to Anxiolytic Compounds and Choice of Danio rerio Line | Q33889976 | ||
| Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition | Q33979466 | ||
| Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. | Q34070779 | ||
| Effects of MDMA on sociability and neural response to social threat and social reward | Q35895888 | ||
| Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management | Q36440881 | ||
| The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review | Q36734781 | ||
| Mice in ecstasy: advanced animal models in the study of MDMA. | Q37737354 | ||
| Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models | Q37814628 | ||
| Zebrafish models to study drug abuse-related phenotypes | Q37880096 | ||
| The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system | Q40665328 | ||
| MDMA produces stimulant-like conditioned locomotor activity | Q41278263 | ||
| Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety | Q41884491 | ||
| A behavioral and molecular analysis of ketamine in zebrafish | Q42027177 | ||
| Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. | Q42256324 | ||
| The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine | Q42595162 | ||
| Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. | Q42844153 | ||
| Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). | Q42988633 | ||
| Characterization of behavioral and endocrine effects of LSD on zebrafish. | Q43012523 | ||
| Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. | Q43024185 | ||
| Analyzing habituation responses to novelty in zebrafish (Danio rerio). | Q43207367 | ||
| Modeling withdrawal syndrome in zebrafish | Q43223690 | ||
| Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans | Q43842050 | ||
| Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion | Q44050776 | ||
| Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors | Q44130894 | ||
| Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala | Q44748253 | ||
| The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test | Q44853105 | ||
| Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. | Q44885616 | ||
| Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). | Q45080355 | ||
| Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression | Q45282493 | ||
| Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression | Q46273251 | ||
| Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. | Q46629357 | ||
| d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex | Q46762432 | ||
| MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). | Q48099202 | ||
| The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
| MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test | Q48369774 | ||
| Anxiolytic effects of nicotine in zebrafish | Q48427347 | ||
| Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor | Q48705199 | ||
| Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. | Q51986361 | ||
| P433 | issue | 3 | |
| P921 | main subject | Danio rerio | Q169444 |
| P304 | page(s) | 275-280 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Behavioural Pharmacology | Q15754239 |
| P1476 | title | Behavioral effects of MDMA ('ecstasy') on adult zebrafish | |
| P478 | volume | 22 |
| Q36056252 | Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors |
| Q38160918 | Anxiolytic drug discovery: what are the novel approaches and how can we improve them? |
| Q37398726 | Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish |
| Q43794099 | Controlled substances and innovation of biomedicine: a preclinical perspective |
| Q33943741 | Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish |
| Q35803439 | Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. |
| Q35375608 | Modeling anxiety using adult zebrafish: a conceptual review |
| Q37113859 | Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds |
| Q51604916 | Spatial distribution of illicit drugs in surface waters of the natural park of Pego-Oliva Marsh (Valencia, Spain). |
| Q41417939 | The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
| Q57298077 | Zebrafish: an emerging real-time model system to study Alzheimer's disease and neurospecific drug discovery |
Search more.